Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation-Reference-Cited by-同舟云学术

Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation

Published:2020-05 Issue:6 Volume:190 Page:851-853
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Pantin Jeremy¹^ORCID,Battiwalla Minoo¹

Affiliation:

1. Sarah Cannon Blood Cancer Network Nashvislle TN USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16685

Reference13 articles.

1. PasquiniM HuntT.Cellular Therapy Registry Update. Center for International Blood and Marrow Transplantation Research.2019. Available from:https://www.cibmtr.org/Meetings/Materials/CRPDMC/_layouts/15/WopiFrame.aspx?sourcedoc=/Meetings/Materials/CRPDMC/Documents/2019/TCT%202019%20MPasquini%20slides%20Cell%20Therapy.pptx&action=default[Accessed 2/4/20].

2. TiceJ WalshJ OtuonyeI ChapmanR KumarV.Chimeric Antigen Receptor T‐Cell Therapy for B‐ Cell Cancers: Effectiveness and Value.2018. Available from:https://icer‐review.org/wp‐content/uploads/2017/07/ICER_CAR_T_Final_Evidence_Report_032318.pdf[Accessed 2/3/2020].

3. Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

4. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma

5. Real-World Quality and Cost Burden of Cytokine Release Syndrome Requiring Tocilizumab or Steroids during CAR-T Infusion Encounter

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach;Advanced Therapeutics;2023-10-15

2. Tumor antigens and immune landscapes identification guided the development of colorectal cancer mRNA vaccines;2023-07-27

3. Single-cell analyses reveal the therapeutic effects of ATHENA and its mechanism in a rhabdomyosarcoma patient;Frontiers in Oncology;2022-11-29

4. Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure;Expert Opinion on Drug Discovery;2022-08-30

5. Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy;Journal of Pharmaceutical Investigation;2022-03-26